Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tresinde Biotech is an India-based pharmaceutical company specializing in the manufacturing and global export of Active Pharmaceutical Ingredients (APIs), pharmaceutical pellets, and intermediates. Founded in 2023 and headquartered in Noida, the company operates as an export-oriented entity serving markets across the Middle East, Africa, and Asia. Its product portfolio includes a wide range of generic therapeutic categories such as antacids (e.g., omeprazole, rabeprazole), cardiac drugs (e.g., losartan, nebivolol), and antibacterials. Tresinde Biotech emphasizes quality control and adherence to international standards, providing research and development services for tailored pharmaceutical solutions alongside its core manufacturing and distribution operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tresinde Biotech.